Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Updates on TAVR in Low-Risk Patients

CME

Updates on TAVR in Low-Risk Patients

Transcatheter Aortic Valve Replacements for Bicuspid Aortic Valves

CME

Transcatheter Aortic Valve Replacements for Bicuspid Aortic Valves

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

CME

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

TAVR in Expanded Patient Populations: Exploring the Next Frontier

CME

TAVR in Expanded Patient Populations: Exploring the Next Frontier

TAVR in 2019: Appropriate Metrics for Success

CME

TAVR in 2019: Appropriate Metrics for Success

TAVR Evolves: Are You and the Heart Team Ready?

CME

TAVR Evolves: Are You and the Heart Team Ready?

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

CME

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Recent TAVR Updates and Upcoming Studies at ACC 2016

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

CME

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

CME

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

Low-Risk Patients: The Changing Face of TAVR

CME

Low-Risk Patients: The Changing Face of TAVR

Expanded TAVR Indications: Post TCT 2016

CME

Expanded TAVR Indications: Post TCT 2016

Defining Cost-Effectiveness and Quality of Life for TAVR

CME

Growing Indications for TAVR in 2018 and Beyond

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.